A City University of New York (CUNY)-affiliated clinical-stage neurotechnology company has been named as the Recipient of the Universal Biotech Innovation Prize 2016 in the global competition that offers “a glimpse of the future of life sciences.” The company, PathMaker Neurosystems (“PathMaker”), has exclusively licensed intellectual property from CUNY developed by neuroscientist Zaghloul Ahmed, PhD, Professor and Chairman, Department of Physical Therapy, College of Staten Island and Professor of Neuroscience, Center for Developmental Neuroscience and CUNY Graduate Center.
As PathMaker’s scientific founder, Dr. Ahmed commented, “We are very pleased to see the international recognition that our groundbreaking technology and world-class team at PathMaker is getting. We are working to bring the novel treatments enabled by our technology to patients as rapidly as possible.”
Read the full article on the EurekAlert.com web site.
